describ
design
synthesi
molecular
model
biolog
evalu
seri
small
molecul
nonpeptid
inhibitor
sarscov
plpro
initi
lead
compound
identifi
via
highthroughput
screen
divers
chemic
librari
subsequ
carri
structureact
relationship
studi
optim
lead
structur
potent
inhibitor
shown
antivir
activ
sarscov
infect
vero
cell
base
upon
xray
crystal
structur
one
potent
inhibitor
sarscov
plpro
drugdesign
templat
creat
structurebas
modif
led
design
potent
inhibitor
enzym
ic
antivir
ec
interestingli
methylamin
deriv
display
good
enzym
inhibitori
potenc
ic
potent
sar
antivir
activ
ec
seri
carri
comput
dock
studi
gener
predict
model
sarscov
plpro
inhibitor
sever
acut
respiratori
syndrom
sar
contagi
fatal
respiratori
ill
first
report
guangdong
provinc
china
novemb
rapidli
spread
asian
countri
north
america
europ
creat
panic
public
world
health
organ
emerg
sar
affect
individu
caus
death
within
month
quit
remark
spread
sarscov
effect
halt
within
month
initi
outbreak
public
health
measur
concert
effort
monitor
scientist
determin
sar
caus
novel
coronaviru
sarscov
recent
isol
strain
zoonot
origin
thought
reservoir
sarscov
emphas
possibl
reemerg
quit
alarm
rapidli
contagi
ill
spread
mobil
highli
interconnect
world
centuri
new
report
sar
case
guarante
outbreak
strike
therefor
develop
antivir
effect
sarscov
import
futur
outbreak
identif
biochem
event
critic
coronavir
lifecycl
provid
number
signific
target
halt
viral
replic
one
earli
essenti
process
cleavag
multidomain
viral
polyprotein
individu
compon
term
nonstructur
protein
nsp
protein
assembl
complex
execut
viral
rna
synthesi
two
cystein
proteas
papainlik
proteas
plpro
proteas
resid
within
polyprotein
catalyz
releas
nsp
polyprotein
initi
virusmedi
rna
replic
sinc
numer
biochem
structur
inhibitor
develop
studi
direct
enzym
cleav
eleven
site
within
polyprotein
recent
report
potent
inhibitor
shown
antivir
activ
sarscov
recent
structur
function
studi
direct
plpro
suggest
potenti
role
proteas
beyond
viral
peptid
cleavag
includ
deubiquitin
deisgyl
involv
viru
evas
innat
immun
respons
furthermor
studi
shown
homolog
enzym
human
coronaviru
essenti
viral
replic
therefor
plpro
emerg
signific
drug
develop
target
screen
structur
divers
librari
compound
led
discoveri
noncoval
lead
inhibitor
figur
ic
valu
racem
mixtur
subsequ
sar
studi
lead
optim
provid
potent
inhibitor
ic
nm
also
inhibit
sarscov
viral
replic
vero
cell
ec
valu
studi
also
report
xray
crystal
structur
sarscov
plpro
bound
inhibitor
reveal
import
molecular
insight
ligandbind
site
interact
describ
full
detail
significantli
extend
studi
includ
design
synthesi
molecular
model
biolog
evalu
seri
inhibitor
sarscov
plpro
shown
scheme
coupl
r
ethylamin
r
ethylamin
benzoic
acid
deriv
util
n
hydrochlorid
edci
hydrat
hobt
presenc
diisopropylethylamin
ch
cl
gave
correspond
inhibitor
excel
yield
inhibitor
synthes
gener
method
nboc
protect
benzoic
acid
deriv
follow
deprotect
boc
group
shown
scheme
protect
paminobenzo
acid
ditbutyl
dicarbon
presenc
triethylamin
mixtur
dioxan
water
h
gave
correspond
tbu
carbam
coupl
reaction
util
edci
hobt
provid
inhibitor
remov
boc
group
trifluoroacet
acid
ch
cl
h
afford
inhibitor
inhibitor
racem
compound
scheme
friedelcraft
reaction
naphthalen
propionyl
chlorid
presenc
aluminum
chlorid
h
gave
ethyl
naphthyl
keton
reduct
amin
inhibitor
nmethyl
amid
prepar
shown
scheme
protect
r
ethylamin
methyl
chloroform
presenc
potassium
carbon
mixtur
dioxan
water
h
afford
carbam
reduct
lithium
aluminum
hydrid
thf
reflux
h
gave
methylamin
coupl
reaction
util
gener
method
provid
inhibitor
inhibitor
prepar
coupl
optic
activ
amin
acid
shown
inhibitor
contain
deriv
synthes
outlin
scheme
reduct
nitro
group
catalyt
hydrogen
presenc
pdc
mixtur
ethyl
acet
methanol
h
provid
inhibitor
acetyl
acet
anhydrid
triethylamin
ch
cl
h
gener
inhibitor
synthesi
inhibitor
gem
dimethyl
group
side
chain
carri
dimethyl
methyl
lithium
presenc
cerium
iii
chlorid
tetrahydrofuran
h
provid
amin
coupl
reaction
use
gener
method
describ
provid
hydrogen
presenc
pdc
mixtur
ethyl
acet
methanol
h
provid
inhibitor
synthesi
substitu
benzamid
moieti
outlin
scheme
iodin
otolu
acid
sodium
perchlorit
potassium
iodid
concentr
sulfur
acid
h
afford
iodid
coupl
reaction
follow
gener
method
provid
inhibitor
cyanat
copper
cyanid
sodium
cyanid
dmf
h
furnish
inhibitor
inhibitor
synthes
esterif
presenc
thionyl
chlorid
methanol
reflux
h
provid
ester
bromin
nbromosuccinimid
benzoyl
peroxid
carbon
tetrachlorid
reflux
h
gener
bromid
reaction
sodium
hydrid
sodium
methoxid
methanol
h
provid
hydrolysi
lithium
hydroxid
monohydr
mixtur
tetrahydrofuran
water
h
afford
acid
coupl
reaction
gener
method
gave
hydrogen
presenc
pdc
ethyl
acet
h
provid
inhibitor
inhibitor
synthes
shown
scheme
reduct
nitro
group
catalyt
hydrogen
presenc
pdc
ethyl
acet
h
provid
amin
reaction
sodium
nitrit
copper
cyanid
sodium
cyanid
acid
condit
h
afford
correspond
benzonitril
reduct
subsequ
nboc
protect
ditbutyl
dicarbon
sodium
borohydrid
presenc
nickel
ii
chlorid
hexahydr
methanol
h
provid
nbocbenzylamin
nmethyl
methyl
iodid
potassium
bi
trimethylsilyl
amid
tetrahydrofuran
h
afford
methylamin
hydrolysi
lithium
hydroxid
monohydr
mixtur
tetrahydrofuran
water
h
gener
acid
coupl
reaction
amin
use
condit
describ
provid
inhibitor
remov
bocgroup
trifluoroacet
acid
dichloromethan
h
gave
inhibitor
inhibitor
prepar
benzylamin
ester
hydrolysi
coupl
result
acid
amin
subsequ
remov
bocgroup
describ
afford
inhibitor
describ
previous
screen
librari
divers
compound
identifi
inhibitor
plpro
activ
sinc
racem
mix
synthes
correspond
chiral
compound
evalu
stereospecif
recognit
compound
plpro
compound
rconfigur
found
twice
potent
racem
compound
rconfigur
compound
ic
compound
ic
therefor
select
rconfigur
compound
optim
lead
compound
shown
tabl
modifi
substitu
benzamid
ring
methyl
methoxi
group
compound
turn
less
potent
lead
compound
thu
methyl
group
ortho
posit
lead
compound
display
potent
activ
ic
methoxi
group
ortho
posit
result
reduct
potenc
compar
lead
compound
methoxi
group
meta
posit
compound
ic
potent
analog
among
methoxi
substitut
deriv
next
attempt
modif
substitu
benzamid
well
naphthyl
ring
result
summar
tabl
shown
deriv
led
increas
ic
valu
compar
lead
compound
compound
ic
bulki
substitu
ortho
para
posit
benzamid
ring
posit
also
result
increas
ic
valu
attempt
improv
potenc
plpro
inhibitor
examin
deriv
also
explor
polar
function
benzamid
ring
base
upon
model
studi
result
shown
tabl
compound
deriv
show
improv
potenc
compar
lead
compound
compound
ic
import
amid
nh
demonstr
nmethyl
deriv
significantli
attenu
potenc
compound
ic
compound
ic
group
result
even
potent
inhibitor
ic
valu
howev
incorpor
polar
acetamid
deriv
afford
less
potent
deriv
compound
ic
obtain
molecular
insight
ligandbind
site
interact
respons
inhibitori
potenc
compound
xray
structur
plpro
complex
determin
previous
resolut
comparison
apoenzym
sarscov
plpro
structur
inhibitor
structur
reveal
signific
conform
differ
structur
base
upon
molecular
insight
modifi
substitu
benzamid
ring
particularli
interest
fact
amin
group
posit
open
cleft
appear
come
within
hydrogen
bond
distanc
hydroxyl
furthermor
number
water
molecul
present
see
figur
occupi
pocket
accommod
r
methyl
substitu
suggest
potenti
extend
methyl
branch
pocket
addit
polar
substitu
shown
tabl
incorpor
dimethyl
group
place
r
methyl
substitu
howev
correspond
inhibitor
show
reduct
potenc
sar
plpro
compound
ic
base
upon
xray
structur
incorpor
substitu
benzamid
ring
result
compound
show
slight
improv
inhibitori
potenc
compound
ic
antivir
activ
ec
shown
tabl
addit
methyl
group
amin
group
provid
compound
show
slightli
decreas
enzym
activ
ic
significantli
improv
antivir
potenc
ec
result
illustr
import
test
compound
abil
inhibit
purifi
protein
also
assess
effect
cell
viabil
inhibit
viral
replic
cellbas
assay
obtain
molecular
insight
activ
site
interact
lead
improv
inhibitori
potenc
creat
energyminim
model
sarscov
plpro
activ
site
figur
model
reveal
substitu
inhibitor
may
involv
hydrogen
bond
side
chain
residu
similar
crystal
structur
conform
compound
compound
appear
anchor
site
two
effect
hydrogen
bond
made
carboxamid
group
residu
gln
three
conserv
water
molecul
found
complex
crystal
structur
compound
protein
crystal
structur
apo
enzym
retain
model
studi
shown
red
dot
bind
pocket
see
figur
dock
studi
water
molecul
necessari
obtain
crystal
bound
orient
compound
posit
naphthyl
ring
inhibitor
flip
upward
hold
loop
shown
cyan
figur
absenc
three
water
naphthyl
ring
tend
occupi
pocket
shown
green
figur
better
quantit
understand
contribut
inhibitor
substitu
inhibitori
potenc
also
conduct
extens
quantit
structur
activ
relationship
qsar
analysi
qsar
studi
often
employ
standard
method
determin
valuabl
inform
design
novel
potent
inhibitor
altern
approach
laborintens
chemic
synthesi
develop
theori
quantit
relat
variat
biolog
activ
chang
molecular
descriptor
compound
goal
comput
studi
develop
robust
qsar
model
predict
differenti
inhibit
valu
seri
inhibitor
sarscov
plpro
partial
least
squar
pl
methodolog
use
analys
comsia
descriptor
use
independ
variabl
percent
inhibit
valu
use
depend
variabl
pl
regress
analys
deriv
model
predict
valu
model
evalu
leaveoneout
loo
crossvalid
assist
ligandbas
structur
design
effort
use
dock
conjug
comsia
investig
sar
inhibitor
consider
structur
divers
wide
rang
bioactiv
sarscov
plpro
crystal
structur
apo
protein
pdb
id
inhibitor
form
pdb
id
care
studi
determin
three
water
molecul
conserv
activ
site
structur
two
buri
deep
pocket
one
residu
apart
three
conserv
water
molecul
two
addit
water
molecul
locat
ridg
pocket
inhibitorbound
form
protein
previous
mention
conduct
extens
analys
without
water
molecul
bound
structur
determin
retain
three
conserv
water
molecul
made
substanti
differ
replic
crystal
structur
bind
geometri
compound
dock
studi
dock
perform
absenc
water
molecul
pocket
studi
suggest
naphthyl
ring
prefer
flip
downward
probabl
find
lower
energi
conform
pocket
shown
figur
inhibitor
crystal
structur
two
conserv
water
molecul
hinder
placement
naphthyl
ring
pocket
therebi
flip
ring
upward
posit
naphthyl
ring
fit
nice
hydrophob
pocket
form
favor
interact
flexibl
loop
residu
five
water
molecul
mention
clearli
shown
figur
retain
dock
procedur
prior
comsia
model
gener
figur
superimposit
naphthyl
ring
model
compound
green
xray
structur
bound
orient
compound
cyan
clearli
shown
obtain
presenc
conserv
water
molecul
use
bind
conform
inhibitor
crystal
structur
templat
inhibitor
dock
dock
geometri
inhibitor
align
well
bind
geometri
compound
crystal
structur
predict
model
deriv
align
dock
conform
inhibitor
extract
directli
coordin
dock
complex
success
comsia
model
built
crossvalid
q
bootstrap
r
imper
mention
without
inclus
least
three
conserv
water
molecul
dock
geometri
inhibitor
align
crystal
structur
shown
figur
absenc
water
molecul
wrong
ligand
conform
gener
naphthyl
ring
flip
pocket
consequ
result
sar
correl
comsia
model
six
compon
gave
crossvalid
q
r
f
mean
standard
error
estim
high
r
illustr
physicochem
descriptor
chosen
appropri
describ
bind
interact
mode
variou
inhibitor
plpro
activ
site
plot
shown
figur
show
correl
experiment
percent
inhibit
valu
compound
inhibit
percentag
predict
comsia
model
contour
map
gener
shown
figur
map
back
topolog
activ
site
reveal
electrostat
hydrophob
steric
field
accord
distribut
bind
site
residu
contour
map
prove
help
determin
incorpor
function
group
inhibitor
extens
interact
specif
bind
pocket
residu
conclud
robust
model
built
use
comsia
use
reliabl
guid
futur
structurebas
drug
design
effort
summari
seri
novel
inhibitor
sarscov
plpro
design
synthes
evalu
enzym
inhibitori
antivir
assay
initi
lead
compound
discov
via
highthroughput
screen
racem
compound
shown
enzym
ic
valu
stereochem
prefer
risom
establish
synthesi
evalu
optic
pure
inhibitor
kinet
studi
show
optic
pure
lead
inhibitor
revers
inhibitor
sarscovplpro
enzym
absenc
structur
inform
initi
structureactivityrelationship
studi
systemat
modif
guid
molecular
model
studi
provid
potent
inhibitor
inhibitor
display
enzym
inhibitori
activ
nm
antivir
ec
valu
sarscov
infect
vero
cell
proteinligand
xray
structur
sarscov
plpro
provid
detail
molecular
interact
activ
site
plpro
enzym
base
upon
xray
structur
inform
structurebas
design
led
identif
potent
inhibitor
inhibitor
shown
potent
enzym
inhibitor
activ
nm
antivir
ec
valu
sar
interestingli
correspond
methylamin
deriv
enzym
ic
shown
potent
antivir
activ
sar
ec
obtain
molecular
insight
bind
properti
deriv
creat
activ
model
base
upon
xray
structur
sar
plpro
appear
methylamin
function
within
proxim
hydrogen
bond
side
chain
residu
also
carri
comput
dock
studi
gener
predict
model
sarscov
plpro
design
revers
sarscov
plpro
inhibitor
current
underway
laboratori
chemistri
hnmr
cnmr
spectra
record
varian
oxford
bruker
avanc
spectromet
optic
rotat
record
perkinelm
polarimet
anhydr
solvent
obtain
follow
dichloromethan
distil
cah
thf
distil
na
benzophenon
solvent
reagent
grade
column
chromatographi
perform
whatman
mesh
silica
gel
low
pressur
psi
tlc
carri
e
merck
silica
gel
plate
puriti
test
compound
determin
hrm
hplc
analysi
agil
unit
two
differ
solvent
system
test
compound
show
puriti
titl
compound
obtain
describ
gener
procedur
yield
white
solid
titl
compound
obtain
describ
gener
procedur
yield
white
solid
titl
compound
obtain
describ
gener
procedur
yield
white
solid
titl
compound
obtain
describ
gener
procedur
yield
white
solid
titl
compound
obtain
describ
gener
procedur
yield
white
solid
titl
compound
obtain
describ
gener
procedur
yield
white
solid
solut
propionyl
chlorid
g
mmol
aluminium
chlorid
g
mmol
ml
ad
dropwis
solut
naphthalen
g
mmol
ml
h
allow
stir
h
reaction
ad
hcl
solut
separ
white
solid
filtrat
wash
water
organ
layer
dri
na
concentr
reduc
pressur
residu
purifi
silica
gel
column
chromatographi
furnish
compound
g
colorless
oil
r
f
hexan
etoac
benzylamin
solut
naphthylphenylketon
mg
mmol
meoh
ml
ad
ammonium
acet
g
mmol
nabh
cn
mg
mmol
allow
stir
h
conc
hcl
ad
ph
solvent
remov
reduc
pressur
residu
taken
water
ml
extract
et
aqueou
layer
brought
ph
solid
koh
extract
ch
cl
organ
layer
dri
na
concentr
reduc
pressur
give
amin
mg
crude
compound
r
f
ch
cl
meoh
titl
compound
obtain
describ
gener
procedur
yield
white
solid
r
f
hexan
etoac
titl
compound
obtain
describ
gener
procedur
yield
white
solid
titl
compound
obtain
describ
compound
yield
slightli
yellow
solid
solut
nitro
mg
mmol
etoacmeoh
ml
ad
pdc
mg
allow
stir
h
h
atmospher
reaction
filter
celit
pad
filtrat
concentr
reduc
pressur
stir
solut
amin
mg
mmol
ch
cl
ml
ad
dropwis
triethylamin
mmol
acet
anhydrid
mmol
allow
stir
h
reaction
quench
satur
nh
cl
solut
extract
ch
cl
organ
layer
dri
na
concentr
reduc
pressur
residu
purifi
silica
gel
column
chromatographi
furnish
compound
mg
white
solid
r
f
ch
cl
meoh
mixtur
stir
min
solut
mg
mmol
thf
ml
ad
stir
continu
h
conc
nh
oh
ml
ad
mixtur
warm
filter
celit
pad
solid
wash
ch
cl
filtrat
extract
ch
cl
organ
layer
dri
na
concentr
reduc
pressur
residu
taken
toluen
ml
stir
h
po
ml
min
toluen
layer
extract
water
x
combin
water
layer
wash
toluen
made
basic
conc
nh
oh
solut
mixtur
extract
ch
cl
organ
layer
dri
na
concentr
reduc
pressur
furnish
compound
mg
colorless
oil
r
f
ch
cl
meoh
titl
compound
obtain
describ
compound
yield
slightli
yellow
solid
titl
compound
obtain
describ
gener
procedur
use
dmfch
cl
solvent
yield
white
solid
mg
mmol
dissolv
dri
dmf
ml
cucn
mg
mmol
crystal
kcn
ad
mixtur
flush
nitrogen
stir
h
h
cucn
mg
mmol
ad
mixtur
flush
nitrogen
stir
h
time
nh
oh
solut
pour
reaction
mixtur
mixtur
extract
acoet
dri
anhydr
na
solvent
evapor
reduc
pressur
purif
silica
gel
flash
column
chromatographi
afford
compound
yield
white
solid
mg
mmol
dissolv
ccl
ml
follow
addit
nb
mg
mmol
catalyt
amount
benzoyl
peroxid
mixtur
stir
reflux
h
anoth
portion
dibenzoyl
peroxid
mg
mmol
ad
mixtur
stir
heat
reflux
anoth
h
mixtur
allow
cool
filter
filtrat
wash
nahco
dri
na
solvent
evapor
vacuo
residu
purifi
silica
gel
column
chromatographi
afford
compound
yield
period
reaction
mixtur
evapor
ml
mixtur
extract
toluen
remov
organ
impur
aqueou
layer
cool
acidifi
aqueou
citric
acid
ph
extract
acoet
dri
anhydr
na
solvent
evapor
purif
silica
gel
flash
column
chromatographi
furnish
compound
yield
ethyl
benzamid
titl
compound
obtain
describ
gener
procedur
use
dmfch
cl
solvent
yield
white
solid
titl
compound
obtain
describ
compound
yield
slightli
yellow
solid
reaction
concentr
reduc
pressur
residu
dilut
satur
nahco
solut
mixtur
extract
et
aqueou
layer
acidifi
hcl
solut
ph
white
solid
extract
etoac
organ
layer
dri
na
concentr
reduc
pressur
provid
correspond
acid
mg
white
solid
r
f
ch
cl
meoh
titl
compound
obtain
describ
gener
procedur
yield
white
solid
r
f
hexan
etoac
r
titl
compound
obtain
describ
compound
yield
white
solid
r
f
ch
cl
meoh
dockinga
genet
algorithm
implement
gold
use
dock
inhibitor
activ
site
ligand
bound
form
sarscov
plpro
crystal
structur
pdb
id
ligand
water
molecul
except
five
name
conserv
conserv
conserv
delet
crystal
structur
ligandbound
form
proteas
polar
hydrogen
atom
ad
use
sybyl
packag
ligand
drawn
use
chem
structur
minim
molecular
mechan
tripo
forc
field
gradient
kcal
mol
addit
hydrogen
atom
ligand
crystal
structur
coordin
bound
ligand
use
refer
molecul
dock
compound
allow
full
ligand
flexibl
automat
consider
caviti
bound
water
molecul
genet
algorithm
paramet
set
default
except
number
oper
increas
popul
size
increment
top
three
conform
gener
dock
softwar
ligand
differ
least
earli
termin
allow
ensur
nonredund
ligand
conform
five
water
molecul
explicitli
defin
dock
configur
file
integr
dock
procedur
result
top
three
conform
save
analysi
best
score
ligand
conform
determin
final
dock
conform
ligand
use
align
proceed
qsar
analysi
comsiath
final
top
score
dock
conform
molecul
retriev
run
mulliken
charg
calcul
fulli
optim
structur
base
method
sybyl
distribut
mopac
result
charg
molecul
align
comsia
analys
explor
specif
contribut
effect
physicochem
properti
bioactiv
virtu
similar
dock
conform
activ
site
sarsplpro
overal
align
need
much
manual
tune
use
qsar
modul
sybyl
spreadsheet
creat
align
molecul
five
physicochem
properti
name
steric
electrostat
hydrophob
field
hydrogen
bond
donor
acceptor
evalu
similar
indic
comput
use
probe
charg
radiu
hydrophob
default
valu
kcalmol
set
maximum
cutoff
steric
electrostat
energi
standard
option
variabl
scale
sampl
method
leaveoneout
cross
valid
perform
determin
optim
princip
compon
number
crossvalid
run
carri
group
round
bootstrap
run
follow
final
comsia
model
obtain
optim
number
compon
noncross
valid
convent
correl
train
set
tune
delet
five
outlier
compound
improv
model
q
valu
consider
henc
result
comsia
model
train
set
consist
molecul
includ
compound
plpro
enzym
residu
express
purifi
e
coli
accord
previous
report
proceedur
ic
valu
inhibitor
determin
use
assay
similar
previous
describ
method
substrat
use
assay
fluorogen
peptid
argleuargglyglyamc
rlrggamc
purchas
bachem
bioscienc
reaction
perform
total
volum
contain
follow
compon
mm
hepe
ph
mgml
bsa
mm
dtt
rlrggamc
dmso
vari
concentr
inhibitor
reaction
initi
addit
plpro
produc
final
enzym
concentr
nm
reaction
progress
monitor
continu
tecan
genio
pro
micropl
reader
excit
nm
emiss
nm
initi
rate
data
fit
equat
vi
vo
ic
use
enzym
kinet
modul
sigmaplot
v
systat
softwar
inc
vi
reaction
rate
presenc
inhibitor
vo
reaction
rate
absenc
inhibitor
inhibitor
concentr
refer
web
version
pubm
central
supplementari
materi
